Latest News
Latest Features
ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes
ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.
Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
Testosterone therapy is recommended in men with hypogonadism to correct symptoms of testosterone deficiency. Men who are otherwise healthy do not need to be screened for hypogonadism.
Case for Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes
An increasing number of studies support the use of continuous glucose monitoring in adult patients with T2D, and the observed benefits are likely to extend to youth with T2D.
Latest Slideshows
The Effects of Alcohol on The Body's Major Systems
Varying degrees of alcohol consumption affect every major organ system.
The Diagnostic Work-Up of Thyroid Nodules: Ruling out Papillary Thyroid Cancer
The American Thyroid Association recently published updated evidence-based guidelines for diagnosing and managing adults with thyroid nodules and differentiated thyroid ...
Latest in Obesity
Better Dietary Patterns Among U.S. Adults Could Save Billions
Increased adherence to healthy dietary patterns could result in health care savings from improved health outcomes.
Metabolic Health Maintenance Key to Preventing CVD
Regardless of long-term metabolic health maintenance, obesity remains a risk factor for cardiovascular disease.
Childhood Obesity/Overweight Steadily Rose From 1999 to 2014
If current trends continue, one-third of children and one-half of adolescents will be obese or overweight by 2030.
Latest in General Endocrinology
Timing of Serum PTH Levels May Predict Postoperative Hypocalcemia
Serum intact parathyroid hormone levels may be an early marker to predict postthyroidectomy hypocalcemia.
Injectable Progestin-Only Contraceptives May Increase Risk for VTE
Investigators examined the effect of progestin-only contraceptive on cardiometabolic outcomes, including stroke, MI, hypertension, diabetes, and VTE.
Hypoparathyroidism Treatment Granted Orphan Drug Designation
TransCon PTH is a long-acting prodrug of parathyroid hormone designed to restore PTH to physiologic levels, normalizing blood and urinary calcium levels, serum phosphate levels and bone turnover.
Endocrinology Advisor Articles
- Predictors of Success for Insulin-to-Liraglutide Switch for Type 2 Diabetes
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Transgender Youth Not Willing to Delay Hormone Therapy for Fertility Preservation
- Pre-Pregnancy Programs May Improve Outcomes in Women With Type 2 Diabetes
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- IV Fluid Infusion Rates Do Not Affect Pediatric DKA Neurologic Outcomes
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Psychiatric Morbidity Decreased After Assisted Reproductive Technology Treatment
- Fenofibrate Improves Cholesterol Levels in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk